Side Effects by the Numbers Nausea How common ~40% Typical duration Peaks within 1 hr, eases over 2-3 hr Flushing How common ~20% Typical duration Transient, under a few hours Injection-site reaction How common ~13% Typical duration Minor, fades same day Headache How common ~11% Typical duration Transient, hours Vomiting How common ~5% Typical duration Early, short-lived Blood-pressure rise How common ~+6/+3 mmHg avg Typical duration Resolves in ~8-12 hr Skin/gum darkening How common ~1% Typical duration Builds with use, may persist Kingsberg SA et al., "Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder" (RECONNECT Phase III trials), Obstet Gynecol, 2019
Changes in the activities and mRNA expression levels of lipoprotein lipase (LPL), hormone-sensitive lipase (HSL) and fatty acid synthetase (FAS) of Nile tilapia ( Oreochromis niloticus ) during fasting and re-feeding
If gradual dose reduction is shown to mitigate weight regain and cardiometabolic deterioration, it may represent a pragmatic and lower-cost approach to long-term obesity management
For many people struggling with metabolic issues, weight loss can be a key factor in improving overall health
